Update on the Feasibility and Progress on Robotic Breast Surgery.

摘要: Robotic nipple-sparing mastectomy (RNSM) may allow for more precise anatomic dissection and improved cosmetic outcomes over conventional open mastectomy; however, data regarding the feasibility safety of procedure are limited. The aim this study was to present discuss perioperative surgical early oncologic follow-up on consecutive patients undergoing RNSM from June 2014 January 2019. Patients underwent immediate robotic breast reconstruction through an axillary incision at a single institution. Perioperative data, complications 3 months postoperatively, pathological adjuvant therapies were recorded. Local recurrence-free, disease-free, overall survival analyzed. Overall, 73 women 94 procedures. Indications invasive cancer in 39 patients, ductal carcinoma situ 17 BRCA mutation patients. Mean surgery time 3 h 32 min. One-step with implant occurred 89.4% rate requiring reoperation 4.3%, flap or nipple necrosis 1.1%. Median 19 months (range 3.1–44.8). No local recurrences occurred. Overall 12, 24, 60 months 98% (95% confidence interval 86–100%). We observed low complication procedures, demonstrating is technically feasible safe. found no failures follow-up. Long-term needed confirm safety. Future clinical trials advantages disadvantages warranted.